Profil

Avatar

Sanja M. Glišić

Zvanje:
Naučni savetnik
Direktni telefoni:
+38111 2453686
Lokal:
627
Naučna oblast:
1
Veće oblasti:
Zastita zdravlja i životne sredine,
Orcid broj:
0000-0001-5691-1055
Organizaciona jedinica:
180

M faktor

Kategorija Broj Koeficijent Ukupno
M11 0 14 0
M12 0 10 0
M13 3 7 21
M14 0 4 0
M15 0 3 0
M16 0 2 0
M17 0 3 0
M18 0 2 0
M21a 4 10 40
M21 27 8 216
M22 10 5 50
M23 6 3 18
M24 0 2 0
M25 0 1.5 0
M26 0 1 0
M27 0 0.5 0
M28a 0 3.5 0
M28b 0 2.5 0
M29a 0 1.5 0
M29b 0 1.5 0
M29v 0 1 0
M31 1 3.5 3.5
M32 4 1.5 6
M33 4 1 4
M34 29 0.5 14.5
M35 0 0.3 0
M36 0 1.5 0
M41 0 7 0
M42 0 5 0
M43 0 3 0
M44 0 2 0
M45 0 1.5 0
M46 0 1 0
M47 0 0.5 0
M48 0 2 0
M49 0 1 0
M51 1 2 2
M52 0 1.5 0
M53 0 1 0
M54 0 0.2 0
M55 0 1 0
M56 0 0.3 0
M57 0 0.2 0
M61 0 1.5 0
M62 0 1 0
M63 0 1 0
M64 2 0.2 0.4
M65 0 0 0
M66 0 1 0
M67 0 0 0
M68 0 0 0
M69 0 0 0
M71 0 6 0
M72 0 3 0
M81 0 0 0
M82 0 0 0
M83 0 0 0
M84 0 0 0
M85 0 0 0
M86 0 0 0
M87 0 0 0
M91 1 0 0
M92 0 0 0
M93 0 0 0
M94 0 0 0
M95 0 0 0
M96 0 0 0
M97 0 0 0
M98 0 0 0
M99 0 0 0
M101 0 0 0
M102 0 0 0
M103 0 0 0
M104 0 0 0
M105 0 0 0
M106 0 0 0
M107 0 0 0
M108 0 0 0
M109 0 0 0
M110 0 0 0
M111 0 0 0
M112 0 0 0
M121 0 3 0
M122 0 2 0
M123 0 1 0
M124 0 1 0

Ukupno M faktor:

375.4
--> -->--> -->--> --> --> -->--> -->--> --> -->-->

NI radovi

# Naziv, Datum, Grupa, Vrsta Godina Autori Status Akcija
1 Design of targeting peptides for nanodrugs for treatment of infectious diseases and cancer.
Drug Targeting and Stimuli Sensitive Drug Delivery Systems‐ ELSEVIER. , , 2018
M10 | M13 		2018 Glisic, S., Veljkovic, V.
Odobren
2 Direct-acting antiviral drugs for treatment of hepatitis C virus infection-clinical trials data and chemistry of NS3/4A protease inhibitors.
Frontiers in Clinical Drug Research: Anti-Infectives , , 2020
M10 | M13 		2020 Sencanski, M., Glisic, S.
Odobren
3 Arginase Flavonoid Anti-Leishmanial in Silico Inhibitors Flagged against Anti-Targets
Molecules , / , 2016
M20 | M21 		2016 Сања Глишић, Милан Сенћански, Владимир Перовић, Страхиња Стевановић, Alfonso T. García-Sosa
Odobren
4 Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
J Proteome Res , , 2020
M20 | M21 		2020 Glisic S, Perovic VR, Sencanski M, Paessler S, Veljkovic V.
Odobren
5 Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3
BMC Bioinformatics , / , 2016
M20 | M21 		2016 Сања Глишић, David P. Cavanaugh, Krishnan K. Chittur, Милан Сенћански, Владимир Перовић, Тијана Бојић
Odobren
6 Critical Impact of Different Conserved Endoplasmic Retention Motifs and Dopamine Receptor Interacting Proteins (DRIPs) on Intracellular Localization and Trafficking of the D 2 Dopamine Receptor (D 2-R) Isoforms
Biomolecules , , 2020
M20 | M21 		2020 Kaja Blagotinšek Cokan , Maša Mavri , Catrin Sian Rutland, Sanja Glišić, Milan Senćanski, Milka Vrecl, Valentina Kubale
Odobren
7 Functional characterization of β2-adrenergic and insulin receptor heteromers
Neuropharmacology , , 2019
M20 | M21 		2019 Maja Susec, Milan Sencanski, Sanja Glisic, Nevena Veljkovic, Christina Pedersen, Luka Drinovec, Jurij Stojan, Jane Nøhr, Milka Vrecl
Odobren
8 In Silico Discovery of a Substituted 6-Methoxy-quinalidine with Leishmanicidal Activity in Leishmania infantum
MOLECULES , / , 2018
M20 | M21 		2018 Stevanovic Strahinja, Perdih Andrej, Sencanski Milan, Glisic Sanja, Duarte Margarida, Tomas Ana M., Sena Filipa V., Sousa Filipe M., Pereira Manuela M., Solmajer Tom
Odobren
9 Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors.
Front Cell Infect Microbiol , , 2019
M20 | M21 		2019 Radosevic D, Sencanski M, Perovic V, Veljkovic N, Prljic J, Veljkovic V, Mantlo E, Bukreyeva N, Paessler S, Glisic S.
Odobren
10 Aerobic exercise training as a potential source of natural antibodies protective against human immunodeficiency virus-1
SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS , / , 2010
M20 | M21a 		2010 Veljkovic M., Dopsaj V., Stringer WW., Sakarellos-Daitsiotis M., Zevgiti S., Вељко Вељковић, Сања Глишић, Dopsaj M.
Odobren
11 Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy
European journal of medicinal chemistry , , 2019
M20 | M21a 		2019 Mirna Jovanović, Daniil Zhukovsky, Ana Podolski-Renić, Ilona Domračeva, Raivis Žalubovskis, Milan Senćanski, Sanja Glišić, Vladimir Sharoyko, Tatiana Tennikova, Dmitry Dar'in, Milica Pešić, Mikhail Krasavin
Odobren
12 In vitro anti-influenza activity of in silico repurposed candidate drug cycrimine.
Antivir Ther , , 2019
M20 | M22 		2019 Matejin S, Bukreyeva N, Radosevic D, Sencanski M, Mantlo E, Veljkovic V, Glisic S, Paessler S.
Odobren
13 Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-Targets.
Molecules , , 2019
M20 | M22 		2019 Stevanovic S, Sencanski M, Danel M, Menendez C, Belguedj R, Bouraiou A, Nikolic K, Cojean S, Loiseau PM, Glisic S, Baltas M, Garcìa-Sosa AT.
Odobren
14 Design of novel NADH dehydrogenase inhibitors as antileishmanial agents
Design of novel NADH dehydrogenase inhibitors as antileishmanial agents , / , 2016
M30 | M32 		2016 С. Стевановић, A. Perdih, С. Глишић, T. Solmajer
Odobren
15 Identification by the Informational Spectrum Method of Giardia protein g14-3-3 domain which is involved in formation of g14-3-3/gCDC7/gDBF4 complex
1st COST CM1307 Conference /CaPF joint meeting , / , 2014
M30 | M34 		2014 Сања Глишић, Marco Lalle, Вељко Вељковић
Odobren
16 M1 targeted vagus nerve stimulation-new therapeutical approach for chronic tinnitus?
*10th International Tinnitus Research Initiative Conference and 1st EU COST action (TINNET) Conference. Tinnitus: subtypes, mechanisms and interventions, 16-18th March 2016, Nottingham, UK. , / , 2016
M30 | M34 		2016 Т. Бојић, М. Сенћански, В. Перовић, С. Глишић
Odobren
17 Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of leishmaniasis
COST Action CM1307 , / , 2017
M30 | M34 		2017 В. Вељковић, N. Fasel, R. Eren, D. Kopelyanskiy, S. Paessler, С. Глишић
Odobren
18 M23
Front Biosci (Landmark Ed) . , , 2022
M20 | M23 		2022 Veljković V, Glišić S, Perović V, Veljković M, Paessler S
Odobren
19 Patterns of human and porcine gammaherpesvirus-encoded BILF1 receptor endocytosis
Cellular & Molecular Biology Letters , , 2023
M20 | M21 		2023 Maša Mavri, Sanja Glišić, Milan Senćanski, Milka Vrecl, Mette M. Rosenkilde, Katja Spiess, Valentina Kubale
Odobren
20 Computational Modeling and Characterization of Peptides Derived from Nanobody Complementary-Determining Region 2 (CDR2) Targeting Active-State Conformation of the β2-Adrenergic Receptor (β2AR)
Biomolecules , , 2024
M20 | M21 		2024 Milan Sencanski, Sanja Glisic, Valentina Kubale, Marko Cotman, Janez Mavri, Milka Vrecl
Odobren
21 Exploring the Antiviral Potential of Natural Compounds against Influenza: A Combined Computational and Experimental Approach
International Journal of Molecular Sciences , , 2024
M20 | M21 		2024 Vladimir Perovic, Kristina Stevanovic, Natalya Bukreyeva, Slobodan Paessler, Junki Maruyama, Sergi López-Serrano, Ayub Darji, Milan Sencanski, Draginja Radosevic, Simone Berardozzi, Bruno Botta, Mattia Mori, Sanja Glisic
Odobren
22 In Silico Exploration of CD200 as a Therapeutic Target for COVID-19
Microorganisms , , 2024
M20 | M22 		2024 Vladimir Perovic, Sanja Glisic, Milena Veljkovic, Slobodan Paessler, Veljko Veljkovic
Odobren

Citati

Broj citata Referenca Status
628.0 Link | Dokument
Odobren